Home
Reels
Grupuri
Pagini
Arata mai mult
Grupuri Pagini Events Blogs Funding
Conecteaza-te Inscrie-te
Night Mode
Triple-Negative Breast Cancer: The Frontline of Innovation in HER2 Negative Disease
Within the HER2 negative breast cancer category, triple-negative breast cancer (TNBC) stands out as the most aggressive and historically most challenging subtype. Lacking estrogen receptors, progesterone receptors, and HER2 expression, TNBC doesn't respond to targeted therapies that benefit other breast cancer types, leaving chemotherapy as the mainstay for decades. That's changing...
0 Commentarii ·0 Distribuiri ·13 Views ·0 previzualizare
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!